The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Like all unspecified codes, D51.9 should be a temporary assignment
Vitamin B12 Injections: Benefits, Energy & Wellness A Boost for Your Energy and Overall Health In todays fast-paced world, many people struggle with low energy, brain fog, and fatigue
Even meat-eaters can become deficient if they have poor methylation, high stress, or chronic fatigue
K., Kuznik, B
None of that becomes direct retatrutide-stack evidence